نتایج جستجو برای: dacarbazine

تعداد نتایج: 1818  

2016
G. V. Long V. Atkinson P. A. Ascierto C. Robert J. C. Hassel P. Rutkowski K. J. Savage F. Taylor C. Coon I. Gilloteau H. B. Dastani I. M. Waxman A. P. Abernethy

BACKGROUND Nivolumab has shown significant survival benefit and a favorable safety profile compared with dacarbazine chemotherapy among treatment-naïve patients with metastatic melanoma in the CheckMate 066 phase III study. Results from the health-related quality of life (HRQoL) analyses from CheckMate 066 are presented. PATIENTS AND METHODS HRQoL was evaluated at baseline and every 6 weeks w...

Journal: :Memo – Magazine of European Medical Oncology 2023

Summary At the turn of past century, unresectable metastatic melanoma was primarily treated with different chemotherapeutic agents, such as dacarbazine, only poor efficacy. Immunotherapeutic interleukin‑2 or adjuvant interferon alpha, were used modest results but frequent side effects. In last 10 years, modern immunotherapy using checkpoint inhibition has dramatically changed treatment landscap...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Thomas K Eigentler Benjamin Weide Filippo de Braud Gianluca Spitaleri Antonella Romanini Annette Pflugfelder Reinerio González-Iglesias Annaelisa Tasciotti Leonardo Giovannoni Kathrin Schwager Valeria Lovato Manuela Kaspar Eveline Trachsel Hans D Menssen Dario Neri Claus Garbe

PURPOSE L19-IL2 is an immunocytokine composed of an antibody fragment specific to the EDB domain of fibronectin, a tumor angiogenesis marker, and of human interleukin-2 (IL2). L19-IL2 delivers IL2 to the tumor site exploiting the selective expression of EDB on newly formed blood vessels. Previously, the recommended dose of L19-IL2 monotherapy was defined as 22.5 million international units (Mio...

2005

MSC (Avemar) is a medical nutriment, which has been shown to support anticancer treatments in colorectal cancer. This 1 year long open-label randornised study compared, in postsurgical adjuvant setting, dacarbazine plus 1 yr long continuous MSC administration (MSC group, 22 patients) vs dacarbazine alone (control group, 24 pts) in stage III malignant skin melanoma. ,4t end-point, there were sig...

2015
Vanessa Shih Renske M. ten Ham Christine T. Bui Dan N. Tran Jie Ting Leslie Wilson

Purpose. Two BRAF(V600E) targeted therapies, dabrafenib and vemurafenib, have received US approval for treatment of metastatic melanoma in BRAF(V600E) patients, a mutation that affects ~50% of patients. We evaluated the cost-effectiveness of BRAF inhibitors and traditional chemotherapy for treatment of metastatic melanoma. Methods. A Markov model was developed using a societal perspective. Tran...

Journal: :Environmental Health Perspectives 1993
S A Kyrtopoulos V L Souliotis C Valavanis V A Boussiotis G A Pangalis

O6-Methylguanine has been measured in peripheral blood leukocytes of 14 patients during one or more cycles of treatment with procarbazine (daily treatment for 10 days) and in 12 patients during one or more cycles of treatment with dacarbazine (single dose per cycle). Adduct formation at levels up to about 0.4 fmole/microgram DNA was detected in all procarbazine- and all but one dacarbazine-trea...

Journal: :Carcinogenesis 2000
A Shiraishi K Sakumi M Sekiguchi

O(6)-methylguanine-DNA methyltransferase plays vital roles in preventing induction of mutations and cancer as well as cell death related to alkylating agents. Mice defective in the MGMT: gene, encoding the methyltransferase, were used to evaluate cell death-inducing and tumorigenic activities of therapeutic agents which have alkylation potential. MGMT(-/-) mice were considerably more sensitive ...

2013
Alessio Amatu Andrea Sartore-Bianchi Catia Moutinho Alessandro Belotti Katia Bencardino Giuseppe Chirico Andrea Cassingena Francesca Rusconi Anna Esposito Michele Nichelatti Manel Esteller Salvatore Siena

Purpose:O-methylguanine-DNA-methyltransferase (MGMT) is a DNA repair protein removing mutagenic and cytotoxic adducts from O-guanine in DNA. Approximately 40% of colorectal cancers (CRC) displayMGMTdeficiency due to the promoter hypermethylation leading to silencing of the gene. Alkylating agents, such as dacarbazine, exert their antitumor activity by DNA methylation at the O-guanine site, indu...

2014
Mengna Chi Yan Ye Xu Dong Zhang Jiezhong Chen

INTRODUCTION There is currently no curative treatment for melanoma once the disease spreads beyond the original site. Although activation of the PI3K/Akt pathway resulting from genetic mutations and epigenetic deregulation of its major regulators is known to cause resistance of melanoma to therapeutic agents, including the conventional chemotherapeutic drug dacarbazine and the Food and Drug Adm...

2017
Selma Ugurel Carmen Loquai Patrick Terheyden Dirk Schadendorf Erika Richtig Jochen Utikal Ralf Gutzmer Knuth Rass Cord Sunderkötter Annette Stein Michael Fluck Martin Kaatz Uwe Trefzer Katharina Kähler Rudolf Stadler Carola Berking Christoph Höller Laura Kerschke Lutz Edler Annette Kopp-Schneider Jürgen C. Becker

Chemotherapy still plays an important role in metastatic melanoma, particularly for patients who are not suitable or have no access to highly efficacious new therapies. Pre-therapeutic chemosensitivity testing might be useful to identify optimal chemotherapy regimens for individual patients. This multicenter randomized phase-3 trial was aimed to test for superiority of chemosensitivity-directed...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید